Fibrin stimulates platelets to increase factor VIIIa binding site expression

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Journal of Thrombosis and Haemostasis

• Publication date

  2004-10-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1111/j.1538-7836.2004.00919.xPMID 15456493
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Lactadherin inhibits enzyme complexes of blood coagulation by competing for phospholipid-binding sites.

  2003cited by this paper
• Platelets and thrombin generation.

  2002cited by this paper
• Phosphorothioate oligonucleotides inhibit the intrinsic tenase complex by an allosteric mechanism.

  2001cited by this paper
• Unique Pathway of Thrombin-induced Platelet Aggregation Mediated by Glycoprotein Ib*

  2001cited by this paper
• Structural and Functional Characterization of Platelet Receptor-mediated Factor VIII Binding*

  2000cited by this paper
• Sites in the A2 subunit involved in the interfactor VIIIa interaction.

  2000cited by this paper
• Peptide Ligands Can Bind to Distinct Sites in Integrin αIIbβ3 and Elicit Different Functional Responses*

  1999cited by this paper
• Peptide ligands can bind to distinct sites in integrin alphaIIbbeta3 and elicit different functional responses.

  1999cited by this paper
• Activation of Factor VIII by Thrombin Increases Its Affinity for Binding to Synthetic Phospholipid Membranes and Activated Platelets*

  1998cited by this paper
• The contribution of the three hypothesized integrin-binding sites in fibrinogen to platelet-mediated clot retraction.

  1998cited by this paper
• Severely Impaired Polymerization of Recombinant Fibrinogen γ-364 Asp → His, the Substitution Discovered in a Heterozygous Individual*

  1997cited by this paper
• Dissecting Clot Retraction and Platelet Aggregation

  1996cited by this paper
• Activation of the Factor VIIIa-Factor IXa Enzyme Complex of Blood Coagulation by Membranes Containing Phosphatidyl-L-serine (*)

  1996cited by this paper
• Inhibition of platelet-mediated, tissue factor-induced thrombin generation by the mouse/human chimeric 7E3 antibody. Potential implications for the effect of c7E3 Fab treatment on acute thrombosis and "clinical restenosis".

  1996cited by this paper
• Calcium involvement in aminophospholipid exposure and microparticle formation during platelet activation: a study using Ca2+-ATPase inhibitors.

  1995cited by this paper
• Locations of disulfide bonds and free cysteines in the heavy and light chains of recombinant human factor VIII (antihemophilic factor A)

  1995cited by this paper
• Continuous analysis of the mechanism of activated transbilayer lipid movement in platelets.

  1995cited by this paper
• Phosphatidylethanolamine Induces High Affinity Binding Sites for Factor VIII on Membranes Containing Phosphatidyl-L-serine (*)

  1995cited by this paper
• Calcium-induced transbilayer scrambling of fluorescent phospholipid analogs in platelets and erythrocytes.

  1994cited by this paper
• Isolation and characterization of thrombin-activated human factor VIII.

  1994cited by this paper
• Contribution of platelet microparticle formation and granule secretion to the transmembrane migration of phosphatidylserine.

  1993cited by this paper
• Adhesive ligand binding to integrin alpha IIb beta 3 stimulates tyrosine phosphorylation of novel protein substrates before phosphorylation of pp125FAK

  1993cited by this paper
• Annexin V as a probe of aminophospholipid exposure and platelet membrane vesiculation: a flow cytometry study showing a role for free sulfhydryl groups.

  1993cited by this paper
• Characterization of purified recombinant fibrinogen: partial phosphorylation of fibrinopeptide A.

  1993cited by this paper
• Thapsigargin Amplifies the Platelet Procoagulant Response Caused by Thrombin

  1993cited by this paper
• Tyrosine phosphorylation and cytoskeletal reorganization in platelets are triggered by interaction of integrin receptors with their immobilized ligands.

  1993cited by this paper
• Defective Ca(2+)-induced microvesiculation and deficient expression of procoagulant activity in erythrocytes from a patient with a bleeding disorder: a study of the red blood cells of Scott syndrome.

  1992cited by this paper
• Modulation of platelet function through adhesion receptors. A dual role for glycoprotein IIb-IIIa (integrin alpha IIb beta 3) mediated by fibrinogen and glycoprotein Ib-von Willebrand factor.

  1992cited by this paper
• Defective Ca(2+)-induced microvesiculation and deficient expression of procoagulant activity in erythrocytes from a patient with a bleeding disorder: a study of the red blood cells of Scott syndrome

  1992cited by this paper
• Specificity of phosphatidylserine-containing membrane binding sites for factor VIII. Studies with model membranes supported by glass microspheres (lipospheres).

  1992cited by this paper
• The effect of plasma von Willebrand factor on the binding of human factor VIII to thrombin-activated human platelets.

  1991cited by this paper
• Platelet-derived microparticles express high affinity receptors for factor VIII.

  1991cited by this paper
• Kinetics of coagulation factor X activation by platelet-bound factor IXa.

  1990cited by this paper
• Platelet receptor-mediated factor X activation by factor IXa. High-affinity factor IXa receptors induced by factor VIII are deficient on platelets in Scott syndrome.

  1989cited by this paper
• Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane. Studies in Scott syndrome: an isolated defect in platelet procoagulant activity.

  1989cited by this paper
• Fibrin protofibril and fibrinogen binding to ADP-stimulated platelets: evidence for a common mechanism.

  1988cited by this paper
• LOCALIZATION OF THE DOMAINS OF FIBRIN INVOLVED IN BINDING TO PLATELETS

  1988cited by this paper
• The binding of 35S-labeled recombinant factor VIII to activated and unactivated human platelets.

  1988cited by this paper
• The role of activated human platelets in prothrombin and factor X activation.

  1985cited by this paper
• Impaired factor X and prothrombin activation associated with decreased phospholipid exposure in platelets from a patient with a bleeding disorder.

  1985cited by this paper
• Changes in membrane phospholipid distribution during platelet activation.

  1983cited by this paper
• Hemostasis and Thrombosis—Basic Principles and Clinical Practice

  1983cited by this paper
• Inhibition of fibrinogen binding to human platelets by the tetrapeptide glycyl-L-prolyl-L-arginyl-L-proline.

  1982cited by this paper
• The role of phospholipid and factor VIIIa in the activation of bovine factor X.

  1981cited by this paper
• Studies on synthetic peptides that bind to fibrinogen and prevent fibrin polymerization. Structural requirements, number of binding sites, and species differences.

  1980cited by this paper
• Studies on the Organisation of Glycoproteins and Proteins in Human Platelet Membranes

  1979cited by this paper

• Discordance between platelet‐supported and vesicle‐supported factor VIII activity in the presence of anti‐C2 domain inhibitory antibodies

  2020cites this paper
• Interplay between platelets and coagulation

  2020cites this paper
• The impact of GPIbα on platelet‐targeted FVIII gene therapy in hemophilia A mice with pre‐existing anti‐FVIII immunity

  2019cites this paper
• The evolving understanding of factor VIII binding sites and implications for the treatment of hemophilia A.

  2019cites this paper
• A booster shot to cure hemoglobinopathies.

  2015cites this paper
• fVIII binds platelets + fibrin: no PS!

  2015cites this paper
• Platelet binding sites for factor VIII in relation to fibrin and phosphatidylserine.

  2015cites this paper
• Novel Role for Galectin-8 Protein as Mediator of Coagulation Factor V Endocytosis by Megakaryocytes*

  2012cites this paper
• Curbing an inhibitor for hemostasis.

  2011cites this paper
• Factor VIII C1 domain residues Lys 2092 and Phe 2093 contribute to membrane binding and cofactor activity.

  2009cites this paper
• Lactadherin blocks thrombosis and hemostasis in vivo: correlation with platelet phosphatidylserine exposure

  2008cites this paper
• The factor VIII C1 domain contributes to platelet binding.

  2008cites this paper
• Thrombin generation assays: understanding how the method influences the results.

  2007cites this paper
• Factor VIII is a positive regulator of platelet function

  2006cites this paper
• Anti-thrombotic action of clopidogrel and PlA1/A2 polymorphism of β3 integrin in patients with coronary artery disease not being treated with aspirin

  2005cites this paper
• Procoagulant activity of adherent platelets

  2005cites this paper